News Highlight Therapeutics trials second-line melanoma combo aft... Cancer immunotherapy has set new standards in care, with some impressive responses in those patients lucky enough to respond.
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
